AREVA Med, an AREVA subsidiary, announced today the future construction of a facility in France that will produce on a large-scale medical grade lead 212. Why Lead-212? Lead-212 is a rare radioactive isotope that lies at the heart of promising nuclear medical research to develop new cancer treatments. Over the past few years, AREVA Med and [...] ...read more